India  

Covishield, Covaxin are safest of Covid-19 vaccines, side-effects are negligible: VK Paul

IndiaTimes Tuesday, 12 January 2021 ()
Covishield and Covaxin, the two Covid-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday and noted that the two "are safest of the vaccines".
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: Covid vaccine: States that received 1st dispatch ahead of Jan 16 roll-out

Covid vaccine: States that received 1st dispatch ahead of Jan 16 roll-out 03:31

Several states in India received the vaccine doses on January 12. Consignment of Covishield was dispatched from Serum Institute of India, Pune. States that received vaccines on January 12 include Delhi, Gujarat, West Bengal, Karnataka, Tamil Nadu, Odisha, Uttar Pradesh, Punjab, and others. The...

💡 newsR Knowledge: Other News Mentions

AZD1222 AZD1222 Vaccine against COVID-19

Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.

Credit: ANI    Duration: 01:30Published

Cambodian PM Hun Sen seeks India's assistance for Covid-19 vaccine

The Cambodian Prime Minister Hun Sen on Monday requested the Indian government to provide the Covid-19 vaccine during his meeting with the new Indian ambassador..
IndiaTimes

Covishield not to be taken by people severely allergic to any of its ingredients: Serum Institute

People who are severely allergic to any ingredient of Covid-19 vaccine 'Covishield' are advised not to take it, Serum Institute of India said. According to the..
IndiaTimes

BBV152 BBV152 Vaccine against COVID-19

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry [Video]

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry

Health and Family Welfare Ministry of India on January 19 said that in case of the Covaxin which has been given emergency use authorization under clinical trial mode (Covaxin), hospitalization cost would be borne by authorities. He said, "There are two vaccines. One of the two vaccines is given emergency use authorization under clinical trial mode. In a document for this vaccine, it's mentioned that if there's causal relation between immunization and adverse event weather it is severe or serious, hospitalization cost would be borne by authorities."

Credit: ANI    Duration: 01:30Published

NITI Aayog NITI Aayog Indian government think tank

NITI Aayog's Dr VK Paul urges doctors, nurses to take COVID vaccine [Video]

NITI Aayog's Dr VK Paul urges doctors, nurses to take COVID vaccine

NITI Aayog Member (Health) Dr VK Paul on January 19 requested doctors and nurses to accept the COVID-19 vaccines with folded hands. VK Paul said, "The concerns about adverse effects and serious problems, as of now, seem to be insignificant and the data show that we are in a comfortable situation and we would like to reassure you that these two COVID-19 vaccines are safe." He further said, "We are not fulfilling our societal responsibility if a vaccine assigned to you is not being taken. The whole world is clamouring for the vaccine. I request the doctors and nurses to accept the vaccine."

Credit: ANI    Duration: 01:54Published
Nasal vaccine candidate identified, could be a game changer: NITI Aayog [Video]

Nasal vaccine candidate identified, could be a game changer: NITI Aayog

NITI Aayog Member (Health) Dr VK Paul on January 19 informed that a nasal vaccine candidate has been identified against COVID-19 that could be a game-changer, if it works. He said, "A nasal vaccine candidate has been identified. It has come for consideration for phase 1 and phase 2 trials. It looks as an exciting development. If it works then it could be a game-changer. We look forward to this development."

Credit: ANI    Duration: 01:14Published
Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.

Credit: HT Digital Content    Duration: 03:41Published

You Might Like


Related videos from verified sources

Side effects of Covishield & Covaxin: Simply Explained | Oneindia News [Video]

Side effects of Covishield & Covaxin: Simply Explained | Oneindia News

For vaccines being administered against the Covid-19, some mild adverse reactions may be expected and in certain cases rare adverse events may occur. All of this is detailed in a fact sheet. This is..

Credit: Oneindia     Duration: 02:15Published
India launches world's largest vaccination drive [Video]

India launches world's largest vaccination drive

India on Saturday (January 16) launched the world's largest vaccination drive after receiving millions of doses of two approved vaccines - Covishield and Covaxin.

Credit: Newsflare STUDIO     Duration: 02:05Published
Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi...

Credit: HT Digital Content     Duration: 06:46Published

Related news from verified sources

Covishield, Covaxin are safest of Covid-19 vaccines, side-effects are negligible: VK Paul

Covishield and Covaxin, the two Covid-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects...
IndiaTimes

Tamil Nadu receives first supply of COVID-19 vaccines

Health Secretary J. Radhakrishnan said the State was allotted 5,56,500 doses of COVID-19 vaccines -- 5,36,500 doses of Covishield vaccine and 20,000 doses of...
Hindu

Covishield vaccine vials for TN’s central districts reach Tiruchi

Health Minister C. Vijayabaskar emphasised that both the vaccines -- Covishield from SII and Covaxin from Bharat Biotech -- have been tested and approved of...
Hindu